FDA Submits Proposed Collection of Information for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in relation to human drug compounding under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.